Literature DB >> 671702

Cooperative study of hospital frequency and character of transient ischemic attacks. VIII. Risk factors.

P M Conneally, M L Dyken, D E Futty, D C Poskanzer, P R Calanchini, P D Swanson, T R Price, A F Haerer, R A Gotshall.   

Abstract

A total of 969 (73%) of 1,328 patients with cases of suspected transient ischemic attacks (TIAs) who came to six institutions during a 21-month period were followed up. Factors were identified and prospectively analyzed for risk for further TIAs, stroke, and deatn. A history of multiple carotid artery TIAs was significantly related to further TIAs. A single TIA placed the patient at greater risk for early infarction. Older age, male sex, and unreliability to take dangerous medication were risk factors for cerebral infarction. Anticoagulant therapy, older age, male sex, diabetes mellitus, heart disease, abnormal ECG, and poor surgical risk were factors for death. The increased mortality associated with anticoagulants was confined to the older age group. While white patients treated with antiplatelet-aggregating agents had a lower mortality than those treated otherwise, this was not true amont black patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671702

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  4 in total

1.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Early risk of stroke after transient ischemic attack: back to the future.

Authors:  Piero Verro
Journal:  CMAJ       Date:  2004-03-30       Impact factor: 8.262

3.  Vertebral artery Doppler sonography.

Authors:  R Winter; S Biedert; T Staudacher; H Betz; R Reuther
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

4.  Amaurosis fugax.

Authors:  W Pryse-Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.